Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

OLED-based bidirectional Neuroimplant

Objective

Neurodegenerative diseases (NDs) affect millions worldwide and have complex causes, including genetic predisposition, environmental factors, drug use, and aging. Currently, there is no cure for most NDs, with treatments mostly aiming to alleviate symptoms and slow disease progression. In general, for any potential therapy, the preservation of neurons and their function—known as neuroprotection—should be a priority. The effectiveness of current therapies, including deep brain stimulation in case of Parkinson’s disease (PD), is limited due to their lack of spatial precision.
The OdiN project aims to develop a flexible, implantable device that enables both neurostimulation and monitoring of neuronal activity. It leverages organic electronics technology, combining near-infrared (NIR) OLEDs to induce photobiomodulation (PBM) for neuroprotection and an OLED–organic photodiode system for detecting neuronal activity. This bidirectional device will be miniaturised to a few hundred micrometres and tested in vitro in a neuronal model of PD, where it will study the effects of PBM on neuroprotection. The device will also be implanted in a PD mouse model to assess its benefits for preventing neurodegeneration in vivo. A technical extension will explore scaling to multi-site stimulation arrays to achieve spatially controlled PBM.
The OdiN project is positioned in the emerging fields of NIR OLED development and PBM, introducing a unique and unprecedented method for precisely targeting neurons without the need for genetic modification. This innovation not only simplifies experimental protocols in animal models but also opens the door to clinical applications that are far more accessible and ethically less problematic than current optogenetic techniques. It holds tremendous promise for advancing the understanding and ultimately the treatment of NDs, offering a tuneable, scalable and minimally invasive implant technology that could revolutionise therapeutic strategies in neuroscience.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-STG

See all projects funded under this call

Host institution

UNIVERSITAT ZU KOLN
Net EU contribution
€ 1 500 000,00
Address
ALBERTUS MAGNUS PLATZ
50931 Koln
Germany
Region
Nordrhein-Westfalen Köln Köln, Kreisfreie Stadt
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 500 000,00

Beneficiaries (1)